...Good morning, everyone. I'm Lisa Walter, Senior Biotech Analyst here at RBC Capital Markets. Thanks for joining us at RBC's Inaugural Ophthalmology Conference. So this morning, we are lucky to have practically the entire management team from Gene Therapy Pioneers 4D Molecular Therapeutics. So please welcome David Kirn, CEO and Co-Founder; Robert Kim, CMO; Chris Simms, Chief Commercial Officer; Dhaval Desai, Chief Development Officer; and Carlos Quezada Ruiz, the Therapeutic Area Head of Development and Ophthalmology. Team, welcome to the conference. David Kirn ...